Skip to main content
Equibles

MORGAN STANLEY

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to LXEO Full portfolio

Position in LXEO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,839,198
-$473,584 QoQ
Shares Held
395,102
-1.9% QoQ
Ownership
0.482%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 141 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. LXEO ranks #222 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in LXEO

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,839,198 395,102
2026-03-31 $2,312,782 402,924
2025-12-31 $1,391,995 140,181
2025-09-30 $651,096 98,057
2025-06-30 $340,817 84,781
2025-03-31 $292,574 84,316
2024-12-31 $492,366 74,828
2024-09-30 $2,186,123 241,828
2024-06-30 $203,113 12,663
2024-03-31 $218,641 13,944
2023-12-31 $127,328 9,488